FDA Staff Supports Remicade Biosimilar

Staff members of the U.S. Food and Drug Administration said on Friday that Celltrion Inc’s biosimilar in form of Remicade an arthritis drug, which is made by Johnson & Johnson, appeared to be highly similar to the branded product. This…


Democratizing access to all financial data. Cutting edge web platform for news and information.

Disclaimer: StocksBeat inform you that the data in this website is not necessarily real-time nor accurate. All prices are not provided by exchanges and prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Stocksbeat doesn`t bear any responsibility for any trading losses you might incur as a result of using the data.